Stockreport

Evaxion establishes new AI-derived precision cancer vaccine concept

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF Evaxion’s AI-Immunology™ platform allows for the design of precision cancer vaccines targeting non-conventional ERV tumor antigens shared across patientsNovel preclinica [Read more]